Closed
Antiretroviral Drugs
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
- Value
- £1,815,556
- Published
- 28 Sept 2026
- Deadline
- 6 Nov 2026
- Procedure
- Not stated
- Category
- 33600000 — Pharmaceutical products
- Location
- UKL, United Kingdom
- Notice reference
- 091362-2026
Requirements summary
NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts) is planning a goods contract for the supply of antiretroviral drugs that are shortly due to lose, or have already lost, patent exclusivity, so competing products will be available in the UK. The estimated value is GBP 1,815,556 gross (GBP 1,512,963 net), with a contract period from 1 April 2027 to 30 June 2028 and an option to extend to 30 June 2029. This is a preliminary market engagement notice; the formal tender is expected to be published later.
Key requirements
- Supply of antiretroviral drugs that are off-patent or nearing patent expiry, with generic or competing alternatives available in the UK
- Supply for All Wales Health Boards and Trusts, delivered within the United Kingdom
- Estimated value of GBP 1,815,556 gross (GBP 1,512,963 net), above the procurement threshold
- Contract period 1 April 2027 to 30 June 2028, with a possible extension to 30 June 2029
- Suitable for SME and VCSE suppliers
- Preliminary market engagement; contact Rachelle Elvin for more information before tender publication
Similar open notices
- Generic Drugs - Oral LiquidsNHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
- Generic Drugs - Oral LiquidsNHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
- NHS National Framework Agreement for Macitentan & Cladribine TabletsNHS England
- Injection Equipment ParaphernaliaThe Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
- Framework for the Provision of Dose Banded Products & Patient Specific Chemotherapy ServicesUniversity Hospitals of Derby and Burton NHS Foundation Trust